Headlands Technologies’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Sell
5,556
-9,839
-64% -$656K 0.04% 487
2026
Q1
$967K Buy
15,395
+2,389
+18% +$166K 0.11% 211
2025
Q4
$863K Sell
13,006
-6,740
-34% -$436K 0.07% 294
2025
Q3
$1.33M Buy
+19,746
New +$1.56M 0.11% 194
2025
Q2
Sell
-24,587
Closed -$1.68M 1267
2025
Q1
$1.68M Buy
24,587
+18,339
+294% +$1.5M 0.19% 122
2024
Q4
$486K Sell
6,248
-8,620
-58% -$638K 0.05% 346
2024
Q3
$997K Buy
+14,868
New +$1.22M 0.11% 193
2023
Q4
Sell
-1,589
Closed -$148K 1029
2023
Q3
$148K Buy
+1,589
New +$179K 0.07% 249

Other funds holding DXCM

Headlands Technologies's DXCM Position: Q2 2026 in Review

Headlands Technologies reduced its DexCom (DXCM) stake by 64% in Q2 2026, selling an estimated $656K and leaving 5,556 shares worth $374K. The position accounts for 0.04% of the portfolio, ranked #487.

Headlands Technologies first reported a position in DXCM in Q3 2023 and has held it in 8 quarters since. The position peaked at $1.68M in Q1 2025. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Headlands Technologies held 5,556 shares of DexCom worth $374K as of Q2 2026.
  • Headlands Technologies sold 9,839 DexCom shares in Q2 2026, an estimated $656K.
  • DexCom made up 0.04% of Headlands Technologies's portfolio in Q2 2026, its #487 holding.
  • Headlands Technologies first reported a position in DexCom in Q3 2023 and has held it in 8 quarters since.
  • Headlands Technologies's DexCom position peaked at $1.68M in Q1 2025.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.